Merck KgaA inks $11B Bio-Techne buyout to expand into cell therapy production
The company is “especially excited” about an immune cell therapy manufacturing technology included in the deal, a Merck KGaA executive said.
Merck KgaA inks $11B Bio-Techne buyout to expand into cell therapy production Read More »
